TABLE 2.
Organism(s) | No. of isolates with indicated result |
||||||
---|---|---|---|---|---|---|---|
KPC | CTX-M (ESBL) | pAmpC |
ESBL+pAmpCb | KPC+pAmpCc | Other/Unknownd | ||
CMY2LATCEF | ACT/MIR | ||||||
Escherichia coli (n = 50) | 2 | 41 | 4 | 2 | 1 | ||
Klebsiella pneumoniae (n = 8) | 2 | 3 | 2 | 1 | 1 | ||
Enterobacter cloacae (n = 5) | 3 | 1 | 1 | ||||
Klebsiella oxytoca (n = 3) | 2 | 1 | |||||
Citrobacter freundii (n = 2) | 1 | 1 | |||||
Enterobacter aerogenes (n = 1) | 1 | ||||||
Pantoea agglomerans (n = 1) | 0 | 1 | |||||
Proteus mirabilis (n = 1) | |||||||
Polymicrobial (n = 6) | 1 | 2 | 1 | 1 | 1 | ||
Total | 7 | 46 | 8 | 3 | 4 | 4 | 5 |
Abbreviations: KPC, Klebsiella pneumoniae carbapenemase; ESBL, extended-spectrum β-lactamase; CRE, carbapenem-resistant Enterobacteriaceae; pAmpC, plasmid-mediated AmpC.
CTX-M plus CMY2LATCEF (n = 3) and CTX-M plus ACT/MIR (n = 1).
KPC plus CMY2LATCEF (n = 3) and KPC plus ACT/MIR (n = 1).
No carbapenemases, ESBLs, or plasmid-mediated AmpCs detected (n = 4) and KPC plus ACT/MIR plus ESBL SHV (n = 1).